☰

Nathan S. Ivey, Ph.D. - Publications

Affiliations: 
US FDA 
Area:
neuroinflammation, neurotoxicology, neurological devices, neuroAIDS, meningitis, neuromicrobiome
Tree Info Grants Similar researchers PubMed Report error

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Renner NA, Ivey NS, Redmann RK, Lackner AA, MacLean AG. MCP-3/CCL7 production by astrocytes: implications for SIV neuroinvasion and AIDS encephalitis. Journal of Neurovirology. 17: 146-52. PMID 21279498 DOI: 10.1007/S13365-010-0017-Y  0.637
2009 Ivey NS, Renner NA, Moroney-Rasmussen T, Mohan M, Redmann RK, Didier PJ, Alvarez X, Lackner AA, MacLean AG. Association of FAK activation with lentivirus-induced disruption of blood-brain barrier tight junction-associated ZO-1 protein organization. Journal of Neurovirology. 15: 312-23. PMID 19521898 DOI: 10.1080/13550280902998413  0.639
2009 Ivey NS, MacLean AG, Lackner AA. Acquired immunodeficiency syndrome and the blood-brain barrier. Journal of Neurovirology. 15: 111-22. PMID 19306229 DOI: 10.1080/13550280902769764  0.646
2005 Ivey NS, Martin EN, Scheld WM, Nathan BR. A new method for measuring blood-brain barrier permeability demonstrated with Europium-bound albumin during experimental lipopolysaccharide (LPS) induced meningitis in the rat. Journal of Neuroscience Methods. 142: 91-5. PMID 15652621 DOI: 10.1016/J.Jneumeth.2004.07.015  0.662
Show low-probability matches.